trihexyphenidyl has been researched along with Acquired Facial Neuropathy in 1 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
Excerpt | Relevance | Reference |
---|---|---|
"Clonic torticollis were less frequently associated to pain." | 1.28 | [Craniocervical dystonia and facial hemispasm: clinical and pharmacological characteristics of 52 patients]. ( Astarloa, R; de Yébenes, JG; Morales, B; Peñafiel, N; Rábano, J, 1991) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Astarloa, R | 1 |
Morales, B | 1 |
Peñafiel, N | 1 |
Rábano, J | 1 |
de Yébenes, JG | 1 |
1 other study available for trihexyphenidyl and Acquired Facial Neuropathy
Article | Year |
---|---|
[Craniocervical dystonia and facial hemispasm: clinical and pharmacological characteristics of 52 patients].
Topics: Adolescent; Adult; Aged; Blepharospasm; Clonazepam; Facial Nerve Diseases; Female; Humans; Male; Mid | 1991 |